{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T01:53:56Z","timestamp":1772243636136,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Henan provincial science and technology research projects","award":["212102310689"],"award-info":[{"award-number":["212102310689"]}]},{"name":"Henan Province Medical Science and technology public relations plan joint project","award":["LHGJ20210001"],"award-info":[{"award-number":["LHGJ20210001"]}]},{"name":"Zhengzhou Collaborative Innovation Major Project","award":["20XTZX05015"],"award-info":[{"award-number":["20XTZX05015"]}]},{"name":"medical science and technology project of Henan Province","award":["SBGJ202101002"],"award-info":[{"award-number":["SBGJ202101002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-024-01445-8","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:02:29Z","timestamp":1730214149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Predictive value of metabolic parameters and apparent diffusion coefficient derived from 18F-FDG PET\/MR in patients with non-small cell lung cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Han","family":"Jiang","sequence":"first","affiliation":[]},{"given":"Ziqiang","family":"Li","sequence":"additional","affiliation":[]},{"given":"Nan","family":"Meng","sequence":"additional","affiliation":[]},{"given":"Yu","family":"Luo","sequence":"additional","affiliation":[]},{"given":"Pengyang","family":"Feng","sequence":"additional","affiliation":[]},{"given":"Fangfang","family":"Fu","sequence":"additional","affiliation":[]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[]},{"given":"Jianmin","family":"Yuan","sequence":"additional","affiliation":[]},{"given":"Zhe","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Meiyun","family":"Wang","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"issue":"2","key":"1445_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"1445_CR2","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.6004\/jnccn.2012.0130","volume":"10","author":"DS Ettinger","year":"2012","unstructured":"Ettinger DS, Akerley W, Borghaei H, et al. Non-small cell lung cancer. J Natl Compr Canc Netw. 2012;10(10):1236\u201371.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"1445_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00259-014-2903-7","volume":"42","author":"HJ Im","year":"2015","unstructured":"Im HJ, Pak K, Cheon GJ, et al. Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging. 2015;42(2):241\u201351.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1445_CR4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s12149-022-01718-8","volume":"36","author":"A Shi","year":"2022","unstructured":"Shi A, Wang J, Wang Y, Guo G, Fan C, Liu J. Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET\/CT for EGFR mutations in non-small cell lung cancer. Ann Nucl Med. 2022;36(4):393\u2013400. https:\/\/doi.org\/10.1007\/s12149-022-01718-8.","journal-title":"Ann Nucl Med"},{"issue":"2","key":"1445_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2214\/AJR.19.21585","volume":"214","author":"X Shao","year":"2020","unstructured":"Shao X, Niu R, Jiang Z, et al. Role of PET\/CT in Management of Early Lung Adenocarcinoma. AJR Am J Roentgenol. 2020;214(2):437\u201345. https:\/\/doi.org\/10.2214\/AJR.19.21585.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"1445_CR6","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/RLU.0000000000003714","volume":"46","author":"D Tosi","year":"2021","unstructured":"Tosi D, Pieropan S, Cattoni M, et al. Prognostic Value of 18F-FDG PET\/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients. Clin Nucl Med. 2021;46(8):621\u20136. https:\/\/doi.org\/10.1097\/RLU.0000000000003714.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"1445_CR7","doi-asserted-by":"publisher","first-page":"e221598","DOI":"10.1148\/radiol.221598","volume":"307","author":"SA Mirshahvalad","year":"2023","unstructured":"Mirshahvalad SA, Metser U, Basso Dias A, et al. 18F-FDG PET\/MRI in Detection of Pulmonary Malignancies: A Systematic Review and Meta-Analysis. Radiology. 2023;307(2):e221598. https:\/\/doi.org\/10.1148\/radiol.221598.","journal-title":"Radiology"},{"issue":"5","key":"1445_CR8","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cllc.2021.03.015","volume":"22","author":"A Moran","year":"2021","unstructured":"Moran A, Wang Y, Dyer BA, et al. Prognostic Value of Computed Tomography and\/or 18F-Fluorodeoxyglucose Positron Emission Tomography Radiomics Features in Locally Advanced Non-small Cell Lung Cancer. Clin Lung Cancer. 2021;22(5):461\u20138.","journal-title":"Clin Lung Cancer"},{"issue":"11","key":"1445_CR9","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.1158\/1078-0432.CCR-18-2495","volume":"25","author":"Y Xu","year":"2019","unstructured":"Xu Y, Hosny A, Zeleznik R, et al. Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging. Clin Cancer Res. 2019;25(11):3266\u201375.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1445_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.mri.2012.07.009","volume":"31","author":"LM Wu","year":"2013","unstructured":"Wu LM, Xu JR, Hua J, et al. Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses? Magn Reson Imaging. 2013;31(2):235\u201346.","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"1445_CR11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s11547-011-0629-1","volume":"116","author":"F Tondo","year":"2011","unstructured":"Tondo F, Saponaro A, Stecco A, Lombardi M, Casadio C, Carriero A. Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum. Radiol Med. 2011;116(5):720\u201333.","journal-title":"Radiol Med"},{"issue":"2","key":"1445_CR12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1148\/radiology.168.2.3393671","volume":"168","author":"D Le Bihan","year":"1988","unstructured":"Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology. 1988;168(2):497\u2013505. https:\/\/doi.org\/10.1148\/radiology.168.2.3393671.","journal-title":"Radiology"},{"issue":"6","key":"1445_CR13","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1002\/jmri.27272","volume":"52","author":"M Bergamino","year":"2020","unstructured":"Bergamino M, Nespodzany A, Baxter LC, et al. Preliminary Assessment of Intravoxel Incoherent Motion Diffusion-Weighted MRI (IVIM-DWI) Metrics in Alzheimer\u2019s Disease. J Magn Reson Imaging. 2020;52(6):1811\u201326. https:\/\/doi.org\/10.1002\/jmri.27272.","journal-title":"J Magn Reson Imaging"},{"key":"1445_CR14","doi-asserted-by":"publisher","unstructured":"Someya Y, Iima M, Imai H, et al. Investigation of breast cancer microstructure and microvasculature from time-dependent DWI and CEST in correlation with histological biomarkers.\u00a0Sci Rep. 2022;12(1):6523. Published 2022 Apr 20. https:\/\/doi.org\/10.1038\/s41598-022-10081-7","DOI":"10.1038\/s41598-022-10081-7"},{"issue":"2","key":"1445_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00330-019-06428-w","volume":"30","author":"S Gao","year":"2020","unstructured":"Gao S, Du S, Lu Z, et al. Multiparametric PET\/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer. Eur Radiol. 2020;30(2):1191\u2013201. https:\/\/doi.org\/10.1007\/s00330-019-06428-w.","journal-title":"Eur Radiol"},{"key":"1445_CR16","doi-asserted-by":"publisher","unstructured":"Liu Y, Wang X, Cui Y, et al. Comparative Study of Monoexponential, Intravoxel Incoherent Motion, Kurtosis, and IVIM-Kurtosis Models for the Diagnosis and Aggressiveness Assessment of Prostate Cancer.\u00a0Front Oncol. 2020;10:1763. Published 2020 Sep 11. https:\/\/doi.org\/10.3389\/fonc.2020.01763","DOI":"10.3389\/fonc.2020.01763"},{"issue":"5","key":"1445_CR17","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/jmri.27977","volume":"55","author":"T Fang","year":"2022","unstructured":"Fang T, Meng N, Feng P, et al. A Comparative Study of Amide Proton Transfer Weighted Imaging and Intravoxel Incoherent Motion MRI Techniques Versus (18) F-FDG PET to Distinguish Solitary Pulmonary Lesions and Their Subtypes. J Magn Reson Imaging. 2022;55(5):1376\u201390. https:\/\/doi.org\/10.1002\/jmri.27977.","journal-title":"J Magn Reson Imaging"},{"key":"1445_CR18","doi-asserted-by":"publisher","unstructured":"Li Z, Luo Y, Jiang H, et al. The value of diffusion kurtosis imaging, diffusion weighted imaging and\u00a018F-FDG PET for differentiating benign and malignant solitary pulmonary lesions and predicting pathological grading.\u00a0Front Oncol. 2022;12:873669. Published 2022 Jul 29. https:\/\/doi.org\/10.3389\/fonc.2022.873669","DOI":"10.3389\/fonc.2022.873669"},{"issue":"1","key":"1445_CR19","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2214\/AJR.11.6525","volume":"198","author":"Y Ohno","year":"2012","unstructured":"Ohno Y, Koyama H, Yoshikawa T, et al. Diffusion-weighted MRI versus 18F-FDG PET\/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. AJR Am J Roentgenol. 2012;198(1):75\u201382.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1445_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/jmri.28691","volume":"58","author":"Y Ohno","year":"2023","unstructured":"Ohno Y, Yui M, Yamamoto K, et al. Chemical Exchange Saturation Transfer MRI: Capability for Predicting Therapeutic Effect of Chemoradiotherapy on Non-Small Cell Lung Cancer Patients. J Magn Reson Imaging. 2023;58(1):174\u201386.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"1445_CR21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.3758\/s13428-015-0623-y","volume":"48","author":"G Shieh","year":"2016","unstructured":"Shieh G. Choosing the best index for the average score intraclass correlation coefficient. Behav Res Methods. 2016;48(3):994\u20131003.","journal-title":"Behav Res Methods"},{"key":"1445_CR22","unstructured":"Abstracts of Presentations at the Association of Clinical Scientists 143rd\u00a0Meeting Louisville, KY May 11\u201314,2022. Ann Clin Lab Sci.2022;52(3):511\u2013525."},{"key":"1445_CR23","doi-asserted-by":"crossref","unstructured":"Messerli M, de Galiza Barbosa F, Marcon M, et al. Value of PET\/MRI for assessing tumor resectability in NSCLC-intra-individual comparison with PET\/CT [published online ahead of print, 2018 Oct 11]. Br J Radiol. 2018;92(1093):20180379.","DOI":"10.1259\/bjr.20180379"},{"issue":"1","key":"1445_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/153303461000900102","volume":"9","author":"HF Wehrl","year":"2010","unstructured":"Wehrl HF, Sauter AW, Judenhofer MS, et al. Combined PET\/MR imaging\u2013technology and applications. Technol Cancer Res Treat. 2010;9(1):5\u201320.","journal-title":"Technol Cancer Res Treat"},{"issue":"4","key":"1445_CR25","first-page":"458","volume":"2","author":"S Balyasnikova","year":"2012","unstructured":"Balyasnikova S, L\u00f6fgren J, de Nijs R, et al. PET\/MR in oncology: an introduction with focus on MR and future perspectives for hybrid imaging. Am J Nucl Med Mol Imaging. 2012;2(4):458\u201374.","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"11","key":"1445_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.molmed.2010.08.003","volume":"16","author":"AW Sauter","year":"2010","unstructured":"Sauter AW, Wehrl HF, Kolb A, et al. Combined PET\/MRI: one step further in multimodality imaging. Trends Mol Med. 2010;16(11):508\u201315.","journal-title":"Trends Mol Med"},{"key":"1445_CR27","doi-asserted-by":"crossref","unstructured":"Liu J, Wu L, Liu Z, et al.\u00a018F-RGD PET\/CT and Systemic Inflammatory Biomarkers Predict Outcomes of Patients With Advanced NSCLC Receiving Combined Antiangiogenic Treatment. Front Oncol.2021;11:671912. Published 2021 Jun 4.","DOI":"10.3389\/fonc.2021.671912"},{"issue":"3","key":"1445_CR28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5578\/tt.3062","volume":"60","author":"V Erdem","year":"2012","unstructured":"Erdem V, Selimo\u011flu \u015een H, K\u00f6mek H, et al. Prognostic factors in non-small cell lung cancer patients and prognostic importance of PET\/CT SUV max value. Tuberk Toraks. 2012;60(3):207\u201317.","journal-title":"Tuberk Toraks"},{"issue":"2","key":"1445_CR29","first-page":"191","volume":"56","author":"C Nawara","year":"2012","unstructured":"Nawara C, Rendl G, Wurstbauer K, et al. The impact of PET and PET\/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy. Q J Nucl Med Mol Imaging. 2012;56(2):191\u2013201.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"1","key":"1445_CR30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1245\/s10434-009-0719-7","volume":"17","author":"SH Hyun","year":"2010","unstructured":"Hyun SH, Choi JY, Shim YM, et al. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol. 2010;17(1):115\u201322.","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"1445_CR31","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1158\/1078-0432.CCR-08-3290","volume":"15","author":"MK Chung","year":"2009","unstructured":"Chung MK, Jeong HS, Park SG, et al. Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography\/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer. Clin Cancer Res. 2009;15(18):5861\u20138.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1445_CR32","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00432-009-0729-7","volume":"136","author":"P Xie","year":"2010","unstructured":"Xie P, Yue JB, Zhao HX, et al. Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma. J Cancer Res Clin Oncol. 2010;136(6):883\u20139.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"12","key":"1445_CR33","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00259-017-3753-x","volume":"44","author":"A Salavati","year":"2017","unstructured":"Salavati A, Duan F, Snyder BS, et al. Optimal FDG PET\/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668\/RTOG 0235 trial. Eur J Nucl Med Mol Imaging. 2017;44(12):1969\u201383.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1445_CR34","doi-asserted-by":"publisher","first-page":"7528971","DOI":"10.1155\/2021\/7528971","volume":"2021","author":"W Wen","year":"2021","unstructured":"Wen W, Piao Y, Xu D, et al. Prognostic Value of MTV and TLG of 18F-FDG PET in Patients with Stage I and II Non-Small-Cell Lung Cancer: a Meta-Analysis. Contrast Media Mol Imaging. 2021;2021:7528971.","journal-title":"Contrast Media Mol Imaging"},{"issue":"2","key":"1445_CR35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1148\/radiol.13130420","volume":"268","author":"D le Bihan","year":"2013","unstructured":"le Bihan D. Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. Radiology. 2013;268(2):318\u201322.","journal-title":"Radiology"},{"issue":"2","key":"1445_CR36","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s00330-015-3840-y","volume":"26","author":"G Shen","year":"2016","unstructured":"Shen G, Jia Z, Deng H. Apparent diffusion coefficient values of diffusion-weighted imaging for distinguishing focal pulmonary lesions and characterizing the subtype of lung cancer: a meta-analysis. Eur Radiol. 2016;26(2):556\u201366.","journal-title":"Eur Radiol"},{"issue":"6","key":"1445_CR37","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.2214\/AJR.06.140","volume":"188","author":"DM Koh","year":"2007","unstructured":"Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology[J]. AJR Am J Roentgenol. 2007;188(6):1622\u201335. https:\/\/doi.org\/10.2214\/AJR.06.140.","journal-title":"AJR Am J Roentgenol"},{"key":"1445_CR38","doi-asserted-by":"crossref","unstructured":"Usuda K, Funasaki A, Sekimura A, et al. FDG-PET\/CT and diffusion-weighted imaging for resected lung cancer: correlation of maximum standardized uptake value and apparent diffusion coefficient value with prognostic factors. Med Oncol. 2018;35(5):66. Published 2018 Apr 9.","DOI":"10.1007\/s12032-018-1128-1"},{"key":"1445_CR39","doi-asserted-by":"crossref","unstructured":"Huang YS, Chen JL, Chen JY, et al. Predicting tumor responses and patient survival in chemoradiotherapy-treated patients with non-small-cell lung cancer using dynamic contrast-enhanced integrated magnetic resonance-positron-emission tomography. Vorhersage von Tumoransprechen und Patienten\u00fcberleben bei den mit Chemoradiotherapie behandelten Patienten mit nicht-kleinzelligem Lungenkrebs mittels dynamischer kontrastverst\u00e4rkter integrierter Magnetresonanz-Positronenemissionstomographie. Strahlenther Onkol. 2019;195(8):707\u2013718.","DOI":"10.1007\/s00066-018-1418-8"},{"issue":"8","key":"1445_CR40","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.21037\/tlcr-21-610","volume":"10","author":"Z Yuan","year":"2021","unstructured":"Yuan Z, Niu XM, Liu XM, et al. Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to predict early response to anti-tumor therapy in advanced non-small cell lung cancer (NSCLC): a comparison of intravoxel incoherent motion-derived parameters and apparent diffusion coefficient. Transl Lung Cancer Res. 2021;10(8):3671\u201381. https:\/\/doi.org\/10.21037\/tlcr-21-610.","journal-title":"Transl Lung Cancer Res"},{"issue":"7","key":"1445_CR41","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1007\/s00330-014-3160-7","volume":"24","author":"EY Lee","year":"2014","unstructured":"Lee EY, Yu X, Chu MM, et al. Perfusion and diffusion characteristics of cervical cancer based on intraxovel incoherent motion MR imaging-a pilot study. Eur Radiol. 2014;24(7):1506\u201313. https:\/\/doi.org\/10.1007\/s00330-014-3160-7.","journal-title":"Eur Radiol"},{"issue":"13","key":"1445_CR42","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1158\/0008-5472.CAN-16-2499","volume":"77","author":"C Shi","year":"2017","unstructured":"Shi C, Liu D, Xiao Z, et al. Monitoring Tumor Response to Antivascular Therapy Using Non-Contrast Intravoxel Incoherent Motion Diffusion-Weighted MRI. Cancer Res. 2017;77(13):3491\u2013501. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2499.","journal-title":"Cancer Res"},{"issue":"8","key":"1445_CR43","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1007\/s00330-014-3176-z","volume":"24","author":"LL Wang","year":"2014","unstructured":"Wang LL, Lin J, Liu K, et al. Intravoxel incoherent motion diffusion-weighted MR imaging in differentiation of lung cancer from obstructive lung consolidation: comparison and correlation with pharmacokinetic analysis from dynamic contrast-enhanced MR imaging. Eur Radiol. 2014;24(8):1914\u201322. https:\/\/doi.org\/10.1007\/s00330-014-3176-z.","journal-title":"Eur Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-024-01445-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-024-01445-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T15:03:22Z","timestamp":1730214202000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-024-01445-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1186\/s12880-024-01445-8","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]},"assertion":[{"value":"27 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of Henan Provincial People's Hospital (2021 Lungren Trial No.148), and the requirement for informed consent was obtained. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}